IL181753A0 - Stable liquid formulations of plasmid dna - Google Patents
Stable liquid formulations of plasmid dnaInfo
- Publication number
- IL181753A0 IL181753A0 IL181753A IL18175307A IL181753A0 IL 181753 A0 IL181753 A0 IL 181753A0 IL 181753 A IL181753 A IL 181753A IL 18175307 A IL18175307 A IL 18175307A IL 181753 A0 IL181753 A0 IL 181753A0
- Authority
- IL
- Israel
- Prior art keywords
- plasmid dna
- liquid formulations
- stable liquid
- stable
- formulations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
- C12N15/68—Stabilisation of the vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2004/011437 WO2005026331A2 (en) | 2003-09-17 | 2004-09-17 | Method of preparation of pharmaceutically grade plasmid dna |
| PCT/EP2005/005213 WO2005100542A1 (en) | 2004-04-19 | 2005-04-19 | Method for purifying plasmid dna |
| PCT/EP2005/010881 WO2006029908A1 (en) | 2004-09-17 | 2005-09-19 | Stable liquid formulations of plasmid dna |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL181753A0 true IL181753A0 (en) | 2007-07-04 |
Family
ID=56290732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL181753A IL181753A0 (en) | 2004-09-17 | 2007-03-06 | Stable liquid formulations of plasmid dna |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1791945A1 (ru) |
| JP (1) | JP2008512997A (ru) |
| KR (1) | KR20070058621A (ru) |
| CN (1) | CN101040041A (ru) |
| AU (1) | AU2005284244A1 (ru) |
| BR (1) | BRPI0515553A (ru) |
| CA (1) | CA2579340A1 (ru) |
| EA (1) | EA011554B1 (ru) |
| IL (1) | IL181753A0 (ru) |
| MX (1) | MX2007003214A (ru) |
| NO (1) | NO20071946L (ru) |
| NZ (1) | NZ553914A (ru) |
| TN (1) | TNSN07087A1 (ru) |
| WO (1) | WO2006029908A1 (ru) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2542385C2 (ru) | 2012-08-31 | 2015-02-20 | Общество с ограниченной ответственностью "НекстГен" | Способ получения фармацевтической композиции для индукции развития кровеносных сосудов в тканях, фармацевтическая композиция, полученная этим способом, и способ лечения ишемии тканей и/или органов человека |
| CN104032005B (zh) * | 2014-06-12 | 2015-11-25 | 成都中创清科医学检验所有限公司 | 一种pcr测序中间产物的保存剂及保存方法 |
| BR112017014090A2 (pt) * | 2014-12-29 | 2018-03-06 | Bonac Corporation | composição, e, métodos para produção de uma composição e estabilização de uma molécula de ácido nucleico. |
| RU2612497C2 (ru) | 2015-05-26 | 2017-03-09 | Общество с ограниченной ответственностью "НекстГен" | Оптимизированная нуклеотидная последовательность и фармацевтическая композиция на ее основе с пролонгированной экспрессией трансгена vegf |
| RU2628087C1 (ru) * | 2016-09-01 | 2017-08-14 | Игорь Валериевич Корниенко | Композиция с противомикробным действием для хранения днк или днк-содержащих препаратов (варианты) и её применение |
| CN106554956A (zh) * | 2016-12-07 | 2017-04-05 | 安徽智飞龙科马生物制药有限公司 | 一种产业化制备BCG‑CpG‑DNA的方法 |
| CN110869501B (zh) * | 2017-08-01 | 2023-08-18 | 深圳华大智造科技股份有限公司 | 一种高效的内切酶缓冲液体系 |
| CA3073462A1 (en) * | 2017-08-25 | 2019-02-28 | Zoetis Services Llc | A method of immobilizing a nucleic acid probe to a solid support |
| CN111433584B (zh) * | 2017-11-22 | 2023-10-31 | 拜克门寇尔特公司 | 稀释剂制备模块和单元 |
| JP2021536241A (ja) * | 2018-08-30 | 2021-12-27 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited | 核酸を検出する方法 |
| CN111718961B (zh) * | 2019-07-03 | 2022-02-08 | 华大青兰生物科技(无锡)有限公司 | 一种用质粒转化细菌的方法 |
| CN115404232A (zh) * | 2021-05-10 | 2022-11-29 | 艾棣维欣(苏州)生物制品有限公司 | 用于提取细菌中质粒dna的方法 |
| KR20230141965A (ko) * | 2022-03-24 | 2023-10-10 | 주식회사 헬릭스미스 | 플라스미드 dna를 포함하는 액체제형 약제학적 조성물 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7807822B2 (en) * | 1996-08-01 | 2010-10-05 | Robert Bridenbaugh | Methods for purifying nucleic acids |
| FR2773818B1 (fr) * | 1998-01-21 | 2000-02-18 | Pasteur Merieux Serums Vacc | Procede et dispositif de lyse de bacteries |
| JP2003516741A (ja) * | 1999-12-17 | 2003-05-20 | メルク エンド カムパニー インコーポレーテッド | コドン最適化ＨＩＶ−１Ｎｅｆ及び修飾ＨＩＶ−１Ｎｅｆを発現するポリヌクレオチドワクチン |
-
2005
- 2005-09-19 BR BRPI0515553-3A patent/BRPI0515553A/pt not_active IP Right Cessation
- 2005-09-19 WO PCT/EP2005/010881 patent/WO2006029908A1/en active Application Filing
- 2005-09-19 KR KR1020077008629A patent/KR20070058621A/ko not_active Application Discontinuation
- 2005-09-19 EP EP05795460A patent/EP1791945A1/en not_active Ceased
- 2005-09-19 NZ NZ553914A patent/NZ553914A/en not_active IP Right Cessation
- 2005-09-19 AU AU2005284244A patent/AU2005284244A1/en not_active Abandoned
- 2005-09-19 EA EA200700656A patent/EA011554B1/ru not_active IP Right Cessation
- 2005-09-19 CN CNA2005800351740A patent/CN101040041A/zh active Pending
- 2005-09-19 CA CA002579340A patent/CA2579340A1/en not_active Abandoned
- 2005-09-19 JP JP2007531725A patent/JP2008512997A/ja active Pending
- 2005-09-19 MX MX2007003214A patent/MX2007003214A/es unknown
-
2007
- 2007-03-06 IL IL181753A patent/IL181753A0/en unknown
- 2007-03-08 TN TNP2007000087A patent/TNSN07087A1/en unknown
- 2007-04-17 NO NO20071946A patent/NO20071946L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20070058621A (ko) | 2007-06-08 |
| CN101040041A (zh) | 2007-09-19 |
| MX2007003214A (es) | 2007-10-11 |
| EA200700656A1 (ru) | 2007-10-26 |
| EA011554B1 (ru) | 2009-04-28 |
| WO2006029908A1 (en) | 2006-03-23 |
| BRPI0515553A (pt) | 2008-07-29 |
| TNSN07087A1 (en) | 2008-06-02 |
| NZ553914A (en) | 2009-11-27 |
| NO20071946L (no) | 2007-05-29 |
| JP2008512997A (ja) | 2008-05-01 |
| AU2005284244A1 (en) | 2006-03-23 |
| CA2579340A1 (en) | 2006-03-23 |
| EP1791945A1 (en) | 2007-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL181753A0 (en) | Stable liquid formulations of plasmid dna | |
| IL187957A0 (en) | Liquid pharmaceutical formulations of docetaxel | |
| EP1981547A4 (en) | STABLE THERAPEUTIC FORMULATIONS | |
| HK1123188A1 (en) | Liquid formulations | |
| HK1102563A1 (en) | Stabilized interferon liquid formulations | |
| IL183252A0 (en) | Solid formulations of liquid biologically active agents | |
| IL177566A0 (en) | Pharmaceutical formulations | |
| PT1986606T (pt) | Formulações líquidas contendo fenilefrina | |
| EP1796632A4 (en) | ORGANOGEL-BASED FORMULATIONS FOR THERAPEUTIC APPLICATIONS | |
| IL192104A0 (en) | Stable protein formulations | |
| ZA200506917B (en) | Liquid pharmaceutical formulations of palonosetron | |
| IL177098A0 (en) | Controlled and sustained delivery of nucleic acid based therapeutic agents | |
| IL181265A0 (en) | Stabilizing formulations | |
| IL178689A0 (en) | Pharmaceutical solution formulations containing 17-aag | |
| GB0426301D0 (en) | Pharmaceutical formulations | |
| EP1740541A4 (en) | THERAPEUTIC FORMULATIONS OF DESOXYEPOTHILONES | |
| GB0406863D0 (en) | Nucleic acid sequencing | |
| GB0423800D0 (en) | New pharmaceutical formulations | |
| GB0416397D0 (en) | Pharmaceutical formulations | |
| SG122904A1 (en) | Nucleic acid preparation | |
| EP1788082A4 (en) | CONSTRUCTION OF NUCLEIC ACIDS | |
| IL181924A0 (en) | Liquid or low melting stabilizer formulations | |
| ZA200702211B (en) | Stable liquid formulations of plasmid DNA | |
| GB0406048D0 (en) | Drug formulations | |
| SI1742618T1 (sl) | Tekoäśe oralne formulacije ospemifena |